IL-17R–EGFR Axis Links Wound Healing to Tumorigenesis in Lrig1+ Stem Cells

Xing Chen,Gang Cai,Caini Liu,Junjie Zhao,Chunfang Gu,Ling Wu,Thomas A. Hamilton,Cun-Jin Zhang,Jennifer Ko,Liang Zhu,Jun Qin,Allison Vidimos,Shlomo Koyfman,Brian R. Gastman,Kim B. Jensen,Xiaoxia Li
DOI: https://doi.org/10.1084/jem.20171849
2018-01-01
The Journal of Experimental Medicine
Abstract:Lrig1 marks a distinct population of stem cells restricted to the upper pilosebaceous unit in normal epidermis. Here we report that IL-17A-mediated activation of EGFR plays a critical role in the expansion and migration of Lrig1(+) stem cells and their progenies in response to wounding, thereby promoting wound healing and skin tumorigenesis. Lrig1-specific deletion of the IL-17R adaptor Act1 or EGFR in mice impairs wound healing and reduces tumor formation. Mechanistically, IL-17R recruits EGFR for IL-17A-mediated signaling in Lrig1(+) stem cells. While TRAF4, enriched in Lrig1(+) stem cells, tethers IL-17RA and EGFR, Act1 recruits c-Src for IL-17A-induced EGFR transactivation and downstream activation of ERK5, which promotes the expansion and migration of Lrig1(+) stem cells. This study demonstrates that IL-17A activates the IL-17R-EGFR axis in Lrig1(+) stem cells linking wound healing to tumorigenesis.
What problem does this paper attempt to address?